Literature DB >> 27638438

Phototherapy: The vitiligo management pillar.

Samia Esmat1, Wedad Mostafa2, Rehab A Hegazy2, Suzan Shalaby2, Vaneeta Sheth3, Randa Youssef2, Medhat El-Mofty2.   

Abstract

Phototherapy has been the mainstay of vitiligo therapy for several decades. A variety of wavelengths and modalities are available, but narrowband ultraviolet B remains the safest and most commonly used treatment. Acting on multiple steps in vitiligo pathogenesis, narrowband ultraviolet B is one of the few therapies that can effectively induce stabilization and stimulate repigmentation. Achievement of optimal results involves using a combination of appropriate treatment protocols, careful patient selection, and patient education to set expectations. Individual patient characteristics, including disease activity, vitiligo phenotype, lesion location, and skin phototype, should all be considered, along with combination therapies.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27638438     DOI: 10.1016/j.clindermatol.2016.05.009

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  2 in total

Review 1.  Deciphering skin re-pigmentation patterns in vitiligo: an update on the cellular and molecular events involved.

Authors:  Tie-Chi Lei; Vincent J Hearing
Journal:  Chin Med J (Engl)       Date:  2020-05-20       Impact factor: 2.628

2.  Therapeutic effects of iNOS inhibition against vitiligo in an animal model.

Authors:  Hamid Mansourpour; Katayoun Ziari; Sahar Kalantar Motamedi; Amin Hassan Poor
Journal:  Eur J Transl Myol       Date:  2019-08-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.